Literature DB >> 21884373

Advancing the biobehavioral research of fatigue with genetics and genomics.

Debra E Lyon1, Nancy L McCain, Rita H Pickler, Cindy Munro, R K Elswick.   

Abstract

PURPOSE: To examine phenotypic considerations in the study of fatigue and to explore significant issues affecting the extension of biobehavioral research of fatigue by the inclusion of genetic and genomic markers. THEORETICAL ORGANIZATION: Fatigue is a condition that has an adverse effect on quality of life that has been a focus of nursing inquiry. Yet, the study of fatigue has been stymied by the lack of phenotypic clarity. To expand the biobehavioral inquiry of fatigue, phenotypic clarity is needed. In addition, examining genomic factors associated with fatigue may help to elucidate the pathophysiology of fatigue and, in the future, lead to targeted interventions that address the molecular basis of fatigue.
CONCLUSIONS: Given that nursing has been at the forefront of the study of fatigue, nurse scientists should consider enhancing phenotypic clarity by the development of a case-definition and use of a core measure of fatigue, one that can be augmented by condition- or population-specific measures as needed. Following the establishment of phenotypic clarity, the integration of genomics into biobehavioral research offers an opportunity for further clarity of phenotypes and for theoretical specification of the pathophysiology of conditions such as fatigue. CLINICAL RELEVANCE: The development of targeted interventions for fatigue depend on a more precise definition of fatigue and a better understanding of the biologic processes that contribute to its development and persistence.
© 2011 Sigma Theta Tau International.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21884373      PMCID: PMC3934428          DOI: 10.1111/j.1547-5069.2011.01406.x

Source DB:  PubMed          Journal:  J Nurs Scholarsh        ISSN: 1527-6546            Impact factor:   3.176


  36 in total

Review 1.  Genomics, gene expression and DNA arrays.

Authors:  D J Lockhart; E A Winzeler
Journal:  Nature       Date:  2000-06-15       Impact factor: 49.962

Review 2.  Candidate-gene approaches for studying complex genetic traits: practical considerations.

Authors:  Holly K Tabor; Neil J Risch; Richard M Myers
Journal:  Nat Rev Genet       Date:  2002-05       Impact factor: 53.242

Review 3.  Fatigue in patients with cancer.

Authors:  Lilian M Nail
Journal:  Oncol Nurs Forum       Date:  2002-04       Impact factor: 2.172

Review 4.  The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans.

Authors:  Marieke Wichers; Michael Maes
Journal:  Int J Neuropsychopharmacol       Date:  2002-12       Impact factor: 5.176

Review 5.  Genome-wide association studies: results from the first few years and potential implications for clinical medicine.

Authors:  Joel N Hirschhorn; Zofia K Z Gajdos
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

Review 6.  Recent advances in the management of biotherapy-related side effects: fatigue.

Authors:  B F Piper; P T Rieger; L Brophy; D Haeuber; L E Hood; A Lyver; E Sharp
Journal:  Oncol Nurs Forum       Date:  1989 Nov-Dec       Impact factor: 2.172

7.  Chronic fatigue.

Authors:  K Potempa; M Lopez; C Reid; L Lawson
Journal:  Image J Nurs Sch       Date:  1986

Review 8.  Fatigue and fatigability.

Authors:  H G Kennedy
Journal:  Br J Psychiatry       Date:  1988-07       Impact factor: 9.319

Review 9.  Fatigue: a concept analysis.

Authors:  E Ream; A Richardson
Journal:  Int J Nurs Stud       Date:  1996-10       Impact factor: 5.837

10.  Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms.

Authors:  Charles S Cleeland; Gary J Bennett; Robert Dantzer; Patrick M Dougherty; Adrian J Dunn; Christina A Meyers; Andrew H Miller; Richard Payne; James M Reuben; Xin Shelley Wang; Bang-Ning Lee
Journal:  Cancer       Date:  2003-06-01       Impact factor: 6.860

View more
  5 in total

1.  Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy.

Authors:  Canhua Xiao; Jonathan J Beitler; Kristin A Higgins; Karen Conneely; Bhakti Dwivedi; Jennifer Felger; Evanthia C Wommack; Dong M Shin; Nabil F Saba; Luke Yeeloo Ong; Jeanne Kowalski; Deborah W Bruner; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2015-10-30       Impact factor: 7.217

Review 2.  Biomarkers: symptoms, survivorship, and quality of life.

Authors:  Christine Miaskowski; Bradley E Aouizerat
Journal:  Semin Oncol Nurs       Date:  2012-05       Impact factor: 2.315

3.  Characterizing fatigue phenotypes with other symptoms and clinically relevant outcomes among people with multiple sclerosis.

Authors:  Matthew Plow; Douglas D Gunzler; Julia H C Chang
Journal:  Qual Life Res       Date:  2022-08-18       Impact factor: 3.440

4.  Recommendations for high-priority research on cancer-related fatigue in children and adults.

Authors:  Andrea M Barsevick; Michael R Irwin; Pamela Hinds; Andrew Miller; Ann Berger; Paul Jacobsen; Sonia Ancoli-Israel; Bryce B Reeve; Karen Mustian; Ann O'Mara; Jin-Shei Lai; Michael Fisch; David Cella
Journal:  J Natl Cancer Inst       Date:  2013-09-18       Impact factor: 13.506

5.  Association Among Glucocorticoid Receptor Sensitivity, Fatigue, and Inflammation in Patients With Head and Neck Cancer.

Authors:  Canhua Xiao; Ronald C Eldridge; Jonathan J Beitler; Kristin A Higgins; Cynthia E Chico; Jennifer C Felger; Evanthia C Wommack; Tish Knobf; Nabil F Saba; Dong M Shin; Deborah W Bruner; Andrew H Miller
Journal:  Psychosom Med       Date:  2020-06       Impact factor: 4.312

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.